Copyright Reports & Markets. All rights reserved.

Global Tuberculosis Diagnostics and Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Skin Testing
      • 1.4.3 Laboratory Testing
    • 1.5 Market by Application
      • 1.5.1 Global Tuberculosis Diagnostics and Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Tuberculosis Diagnostics and Treatment Market Size
    • 2.2 Tuberculosis Diagnostics and Treatment Growth Trends by Regions
      • 2.2.1 Tuberculosis Diagnostics and Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Tuberculosis Diagnostics and Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Tuberculosis Diagnostics and Treatment Market Size by Manufacturers
      • 3.1.1 Global Tuberculosis Diagnostics and Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Tuberculosis Diagnostics and Treatment Key Players Head office and Area Served
    • 3.3 Key Players Tuberculosis Diagnostics and Treatment Product/Solution/Service
    • 3.4 Date of Enter into Tuberculosis Diagnostics and Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Tuberculosis Diagnostics and Treatment Market Size by Type (2014-2019)
    • 4.2 Global Tuberculosis Diagnostics and Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Tuberculosis Diagnostics and Treatment Market Size (2014-2019)
    • 5.2 Tuberculosis Diagnostics and Treatment Key Players in United States
    • 5.3 United States Tuberculosis Diagnostics and Treatment Market Size by Type
    • 5.4 United States Tuberculosis Diagnostics and Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Tuberculosis Diagnostics and Treatment Market Size (2014-2019)
    • 6.2 Tuberculosis Diagnostics and Treatment Key Players in Europe
    • 6.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Type
    • 6.4 Europe Tuberculosis Diagnostics and Treatment Market Size by Application

    7 China

    • 7.1 China Tuberculosis Diagnostics and Treatment Market Size (2014-2019)
    • 7.2 Tuberculosis Diagnostics and Treatment Key Players in China
    • 7.3 China Tuberculosis Diagnostics and Treatment Market Size by Type
    • 7.4 China Tuberculosis Diagnostics and Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Tuberculosis Diagnostics and Treatment Market Size (2014-2019)
    • 8.2 Tuberculosis Diagnostics and Treatment Key Players in Japan
    • 8.3 Japan Tuberculosis Diagnostics and Treatment Market Size by Type
    • 8.4 Japan Tuberculosis Diagnostics and Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Tuberculosis Diagnostics and Treatment Market Size (2014-2019)
    • 9.2 Tuberculosis Diagnostics and Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Tuberculosis Diagnostics and Treatment Market Size by Type
    • 9.4 Southeast Asia Tuberculosis Diagnostics and Treatment Market Size by Application

    10 India

    • 10.1 India Tuberculosis Diagnostics and Treatment Market Size (2014-2019)
    • 10.2 Tuberculosis Diagnostics and Treatment Key Players in India
    • 10.3 India Tuberculosis Diagnostics and Treatment Market Size by Type
    • 10.4 India Tuberculosis Diagnostics and Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Tuberculosis Diagnostics and Treatment Market Size (2014-2019)
    • 11.2 Tuberculosis Diagnostics and Treatment Key Players in Central & South America
    • 11.3 Central & South America Tuberculosis Diagnostics and Treatment Market Size by Type
    • 11.4 Central & South America Tuberculosis Diagnostics and Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Cepheid Inc
      • 12.1.1 Cepheid Inc Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Tuberculosis Diagnostics and Treatment Introduction
      • 12.1.4 Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2014-2019)
      • 12.1.5 Cepheid Inc Recent Development
    • 12.2 Becton Dickinson
      • 12.2.1 Becton Dickinson Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Tuberculosis Diagnostics and Treatment Introduction
      • 12.2.4 Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2014-2019)
      • 12.2.5 Becton Dickinson Recent Development
    • 12.3 Hain LifeSciences
      • 12.3.1 Hain LifeSciences Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Tuberculosis Diagnostics and Treatment Introduction
      • 12.3.4 Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2014-2019)
      • 12.3.5 Hain LifeSciences Recent Development
    • 12.4 Abbott Laboratories
      • 12.4.1 Abbott Laboratories Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Tuberculosis Diagnostics and Treatment Introduction
      • 12.4.4 Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2014-2019)
      • 12.4.5 Abbott Laboratories Recent Development
    • 12.5 Alere, Inc
      • 12.5.1 Alere, Inc Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Tuberculosis Diagnostics and Treatment Introduction
      • 12.5.4 Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2014-2019)
      • 12.5.5 Alere, Inc Recent Development
    • 12.6 Roche AG
      • 12.6.1 Roche AG Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Tuberculosis Diagnostics and Treatment Introduction
      • 12.6.4 Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2014-2019)
      • 12.6.5 Roche AG Recent Development
    • 12.7 Hologic Corporation
      • 12.7.1 Hologic Corporation Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Tuberculosis Diagnostics and Treatment Introduction
      • 12.7.4 Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2014-2019)
      • 12.7.5 Hologic Corporation Recent Development
    • 12.8 bioMerieux
      • 12.8.1 bioMerieux Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Tuberculosis Diagnostics and Treatment Introduction
      • 12.8.4 bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2014-2019)
      • 12.8.5 bioMerieux Recent Development
    • 12.9 Sanofi
      • 12.9.1 Sanofi Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Tuberculosis Diagnostics and Treatment Introduction
      • 12.9.4 Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2014-2019)
      • 12.9.5 Sanofi Recent Development
    • 12.10 QIAGEN
      • 12.10.1 QIAGEN Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Tuberculosis Diagnostics and Treatment Introduction
      • 12.10.4 QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2014-2019)
      • 12.10.5 QIAGEN Recent Development
    • 12.11 Akonni Biosystems, Inc.
    • 12.12 Epistem Holdings Plc
    • 12.13 Gen-Probe Inc.
    • 12.14 EIKEN Chemical
    • 12.15 Thermo Fisher Scientific, Inc

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Tuberculosis refer to the infectious bacterial disease characterized by the growth of nodules (tubercles) in the tissues, especially the lungs.
      In 2018, the global Tuberculosis Diagnostics and Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Tuberculosis Diagnostics and Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tuberculosis Diagnostics and Treatment development in United States, Europe and China.

      The key players covered in this study
      Cepheid Inc
      Becton Dickinson
      Hain LifeSciences
      Abbott Laboratories
      Alere, Inc
      Roche AG
      Hologic Corporation
      bioMerieux
      Sanofi
      QIAGEN
      Akonni Biosystems, Inc.
      Epistem Holdings Plc
      Gen-Probe Inc.
      EIKEN Chemical
      Thermo Fisher Scientific, Inc

      Market segment by Type, the product can be split into
      Skin Testing
      Laboratory Testing

      Market segment by Application, split into
      Hospital
      Clinic
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Tuberculosis Diagnostics and Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Tuberculosis Diagnostics and Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Tuberculosis Diagnostics and Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now